tradingkey.logo

DarioHealth Corp

DRIO
查看详细走势图
11.540USD
-1.300-10.12%
收盘 12/19, 16:00美东报价延迟15分钟
78.10M总市值
亏损市盈率 TTM

DarioHealth Corp

11.540
-1.300-10.12%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-10.12%

5天

-2.94%

1月

-17.01%

6月

-16.38%

今年开始到现在

-26.60%

1年

-27.88%

查看详细走势图

TradingKey DarioHealth Corp股票评分

单位: USD 更新时间: 2025-12-19

操作建议

DarioHealth Corp当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名121/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价18.25。中期看,股价处于下降通道。近一个月,市场表现非常差,但技术面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

DarioHealth Corp评分

相关信息

行业排名
121 / 208
全市场排名
288 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 4 位分析师
买入
评级
18.250
目标均价
+50.21%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

DarioHealth Corp亮点

亮点风险
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
业绩增长期
公司处于发展阶段,最新年度总收入27.04M美元
估值合理
公司最新PE估值-1.04,处于3年历史合理位
机构加仓
最新机构持股795.75K股,环比增加0.01%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值30.40K

DarioHealth Corp新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

DarioHealth Corp简介

DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
公司代码DRIO
公司DarioHealth Corp
CEORaphael (Erez)
网址https://shop.mydario.com/

常见问题

DarioHealth Corp(DRIO)的当前股价是多少?

DarioHealth Corp(DRIO)的当前股价是 11.540。

DarioHealth Corp的股票代码是什么?

DarioHealth Corp的股票代码是DRIO。

DarioHealth Corp股票的52周最高点是多少?

DarioHealth Corp股票的52周最高点是31.000。

DarioHealth Corp股票的52周最低点是多少?

DarioHealth Corp股票的52周最低点是5.935。

DarioHealth Corp的市值是多少?

DarioHealth Corp的市值是78.10M。

DarioHealth Corp的净利润是多少?

DarioHealth Corp的净利润为-40.98M。

现在DarioHealth Corp(DRIO)的股票是买入、持有还是卖出?

根据分析师评级,DarioHealth Corp(DRIO)的总体评级为买入,目标价格为18.250。

DarioHealth Corp(DRIO)股票的每股收益(EPS TTM)是多少

DarioHealth Corp(DRIO)股票的每股收益(EPS TTM)是-11.073。
KeyAI